LARIMAR THERAPEUTICS INC filings

SEC filings by LARIMAR THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-03-15Flynn James ELarimar Therapeutics, Inc.6,151,3899.6%EDGAR
SC 13G2024-02-26RA CAPITAL MANAGEMENT, L.P.Larimar Therapeutics, Inc.6,045,3519.5%EDGAR
SC 13D/A2024-02-16Flynn James ELarimar Therapeutics, Inc.6,151,38910.1%EDGAR
SC 13D/A2024-02-15Flynn James ELarimar Therapeutics, Inc.4,721,18310.8%EDGAR
SC 13G/A2024-02-14PERCEPTIVE ADVISORS LLCLarimar Therapeutics, Inc.00.0%EDGAR
SC 13G2024-02-14Verition Fund Management LLCLarimar Therapeutics, Inc.2,811,1316.4%EDGAR
SC 13G2024-02-14Blue Owl Capital Holdings LPLarimar Therapeutics, Inc.3,414,4687.8%EDGAR
SC 13G/A2024-02-13JANUS HENDERSON GROUP PLCLarimar Therapeutics, Inc.2,641,0656.0%EDGAR
SC 13G2023-08-18JANUS HENDERSON GROUP PLCLarimar Therapeutics, Inc.2,191,4115.1%EDGAR
SC 13D/A2023-03-17Flynn James ELarimar Therapeutics, Inc.4,721,18310.9%EDGAR
SC 13G2023-02-14PERCEPTIVE ADVISORS LLCLarimar Therapeutics, Inc.2,860,0006.6%EDGAR
SC 13G/A2023-02-13CHI Advisors LLCLarimar Therapeutics, Inc.3,473,3668.0%EDGAR
SC 13G/A2023-01-23Opaleye Management Inc.Larimar Therapeutics, Inc.1,560,0003.6%EDGAR
SC 13G/A2022-11-14RA CAPITAL MANAGEMENT, L.P.Larimar Therapeutics, Inc.00.0%EDGAR
SC 13D/A2022-09-16Flynn James ELarimar Therapeutics, Inc.4,721,18311.8%EDGAR
SC 13G2022-02-18Opaleye Management Inc.Larimar Therapeutics, Inc.943,7025.3%EDGAR
SC 13G/A2022-02-15ACUTA CAPITAL PARTNERS, LLCLarimar Therapeutics, Inc.00.0%EDGAR
SC 13G/A2022-02-14RA CAPITAL MANAGEMENT, L.P.Larimar Therapeutics, Inc.1,334,6107.5%EDGAR
SC 13G/A2022-02-11ORBIMED ADVISORS LLCLarimar Therapeutics, Inc.00.0%EDGAR
SC 13G/A2022-02-11CHI Advisors LLCLarimar Therapeutics, Inc.1,515,1488.6%EDGAR